Brain Tumors, Head and Neck Cancers,Gynecological Malignancies
CLINICAL TRIALS
RTOG-3507 - KEYSTROKE: A Randomized Phase II Study of Pembrolizumab (Keytruda®) PLUS Stereotactic Re-Irradiation versus SBRT Alone for Locoregionally Recurrent or Second Primary Head and Neck Carcinoma Read more
Randomized Phase II/III Trial of Adjuvant Radiation Therapy with Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck Read more
